NO20080754L - Rotavirusvaksine som induserer heterotypisk kryss-beskyttelse - Google Patents

Rotavirusvaksine som induserer heterotypisk kryss-beskyttelse

Info

Publication number: NO20080754L
Authority: NO; Norway
Prior art keywords: induces; protection; rotavirus vaccine; heterotypic cross; heterotypic
Prior art date: 2005-08-17

Application number

NO20080754A

Other languages

English (en)

Norwegian (no)

Inventor

Brigitte Desiree Alberte Colau

Beatrice Arsene Virginie De Vos

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-08-17

Filing date

2008-02-12

Publication date

2008-05-15

2005-08-17 Priority claimed from GB0516944A external-priority patent/GB0516944D0/en

2005-10-18 Priority claimed from GB0521164A external-priority patent/GB0521164D0/en

2006-05-05 Priority claimed from GB0608962A external-priority patent/GB0608962D0/en

2008-02-12 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2008-05-15 Publication of NO20080754L publication Critical patent/NO20080754L/no

Links

229940124859 Rotavirus vaccine Drugs 0.000 title 1
241000702670 Rotavirus Species 0.000 abstract 3
230000028993 immune response Effects 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
230000002238 attenuated effect Effects 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO20080754A 2005-08-17 2008-02-12 Rotavirusvaksine som induserer heterotypisk kryss-beskyttelse NO20080754L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0516944A GB0516944D0 (en)	2005-08-17	2005-08-17	Vaccine
GB0521164A GB0521164D0 (en)	2005-10-18	2005-10-18	Vaccine
GB0608962A GB0608962D0 (en)	2006-05-05	2006-05-05	Vaccine
PCT/EP2006/008094 WO2007020078A2 (fr)	2005-08-17	2006-08-15	Vaccin

Publications (1)

Publication Number	Publication Date
NO20080754L true NO20080754L (no)	2008-05-15

Family

ID=37757924

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20080754A NO20080754L (no)	2005-08-17	2008-02-12	Rotavirusvaksine som induserer heterotypisk kryss-beskyttelse

Country Status (25)

Country	Link
US (1)	US20090028828A1 (fr)
EP (2)	EP1915173A2 (fr)
JP (1)	JP5519934B2 (fr)
KR (1)	KR20080036648A (fr)
AR (1)	AR054916A1 (fr)
AU (1)	AU2006281566B2 (fr)
BR (1)	BRPI0615203A2 (fr)
CA (1)	CA2619751C (fr)
CR (1)	CR9759A (fr)
CY (1)	CY1116135T1 (fr)
DK (1)	DK2233153T3 (fr)
EA (1)	EA014328B1 (fr)
ES (1)	ES2534637T3 (fr)
HR (1)	HRP20150310T1 (fr)
IL (1)	IL189289A0 (fr)
MA (1)	MA29700B1 (fr)
MX (1)	MX2008002270A (fr)
NO (1)	NO20080754L (fr)
PE (1)	PE20070235A1 (fr)
PL (1)	PL2233153T3 (fr)
PT (1)	PT2233153E (fr)
SG (1)	SG163571A1 (fr)
SI (1)	SI2233153T1 (fr)
TW (1)	TW200740457A (fr)
WO (1)	WO2007020078A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0107510D0 (en)	2001-03-26	2001-05-16	Univ Bristol	New elongase gene and a process for the production of -9-polyunsaturated fatty acids
EP2197283B1 (fr) *	2007-09-25	2013-07-17	Aridis Pharmaceuticals	Formulations pour la préservation de rotavirus
US9311112B2 (en) *	2009-03-16	2016-04-12	Apple Inc.	Event recognition
CN103747800A (zh) *	2011-04-28	2014-04-23	国际医学基金会	液体疫苗制剂
CN110227152A (zh) *	2012-04-23	2019-09-13	巴拉特生物技术国际有限公司	轮状病毒疫苗组合物及其制备方法
EP3359651A1 (fr)	2015-10-05	2018-08-15	THE UNITED STATES OF AMERICA, represented by the S	Souche de rotavirus humain g9p[6]et utilisation comme vaccin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992008786A1 (fr) *	1990-11-16	1992-05-29	James N. Gamble Institute Of Medical Research	Rotavirus humains, vaccins et procedes
SK287261B6 (sk) *	1999-08-17	2010-04-07	Smithkline Beecham Biologicals S.A.	Oslabená ľudská rotavírusová populácia, spôsob jej výroby, vakcínový prostriedok s jej obsahom a jej použitie
MXPA06002459A (es) *	2003-09-02	2006-06-20	Glaxosmithkline Biolog Sa	Vacuna.

2006
- 2006-08-15 JP JP2008526443A patent/JP5519934B2/ja not_active Expired - Lifetime
- 2006-08-15 TW TW095129956A patent/TW200740457A/zh unknown
- 2006-08-15 WO PCT/EP2006/008094 patent/WO2007020078A2/fr not_active Ceased
- 2006-08-15 AR ARP060103557A patent/AR054916A1/es not_active Application Discontinuation
- 2006-08-15 SG SG201004843-7A patent/SG163571A1/en unknown
- 2006-08-15 PE PE2006000993A patent/PE20070235A1/es not_active Application Discontinuation
- 2006-08-15 PL PL10159949T patent/PL2233153T3/pl unknown
- 2006-08-15 EP EP06776899A patent/EP1915173A2/fr not_active Ceased
- 2006-08-15 CA CA2619751A patent/CA2619751C/fr not_active Expired - Lifetime
- 2006-08-15 MX MX2008002270A patent/MX2008002270A/es unknown
- 2006-08-15 ES ES10159949.6T patent/ES2534637T3/es not_active Expired - Lifetime
- 2006-08-15 KR KR1020087006496A patent/KR20080036648A/ko not_active Ceased
- 2006-08-15 DK DK10159949T patent/DK2233153T3/da active
- 2006-08-15 EP EP10159949.6A patent/EP2233153B1/fr not_active Expired - Lifetime
- 2006-08-15 US US12/063,602 patent/US20090028828A1/en not_active Abandoned
- 2006-08-15 BR BRPI0615203-1A patent/BRPI0615203A2/pt not_active Application Discontinuation
- 2006-08-15 PT PT101599496T patent/PT2233153E/pt unknown
- 2006-08-15 SI SI200631912T patent/SI2233153T1/sl unknown
- 2006-08-15 EA EA200800320A patent/EA014328B1/ru not_active IP Right Cessation
- 2006-08-15 AU AU2006281566A patent/AU2006281566B2/en not_active Ceased
2008
- 2008-02-05 IL IL189289A patent/IL189289A0/en unknown
- 2008-02-12 NO NO20080754A patent/NO20080754L/no not_active Application Discontinuation
- 2008-02-13 MA MA30653A patent/MA29700B1/fr unknown
- 2008-02-22 CR CR9759A patent/CR9759A/es not_active Application Discontinuation
2015
- 2015-03-18 HR HRP20150310TT patent/HRP20150310T1/hr unknown
- 2015-03-23 CY CY20151100289T patent/CY1116135T1/el unknown

Also Published As

Publication number	Publication date
EA200800320A1 (ru)	2008-10-30
JP5519934B2 (ja)	2014-06-11
EA014328B1 (ru)	2010-10-29
PL2233153T3 (pl)	2015-06-30
SI2233153T1 (sl)	2015-05-29
DK2233153T3 (da)	2015-04-27
TW200740457A (en)	2007-11-01
JP2009504701A (ja)	2009-02-05
WO2007020078A2 (fr)	2007-02-22
AU2006281566B2 (en)	2011-09-01
PE20070235A1 (es)	2007-04-04
MX2008002270A (es)	2008-03-27
ES2534637T3 (es)	2015-04-27
KR20080036648A (ko)	2008-04-28
US20090028828A1 (en)	2009-01-29
IL189289A0 (en)	2008-06-05
SG163571A1 (en)	2010-08-30
BRPI0615203A2 (pt)	2011-05-10
MA29700B1 (fr)	2008-08-01
EP2233153B1 (fr)	2015-01-21
CA2619751A1 (fr)	2007-02-22
CR9759A (es)	2008-05-05
CY1116135T1 (el)	2017-02-08
PT2233153E (pt)	2015-04-20
WO2007020078A3 (fr)	2007-05-24
AR054916A1 (es)	2007-07-25
HRP20150310T1 (hr)	2015-06-19
EP1915173A2 (fr)	2008-04-30
AU2006281566A1 (en)	2007-02-22
CA2619751C (fr)	2016-07-05
EP2233153A1 (fr)	2010-09-29

Legal Events

Date	Code	Title	Description
2014-03-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
WO2011027222A3 (fr)	2011-05-05	Compositions immunogènes comprenant des modulateurs de l'activité tlr
MX2012002654A (es)	2012-03-26	Compuestos y composiciones como moduladores de la actividad de tlr.
CA2891358C (fr)	2021-05-18	Derives de 5-fluoro-n-(pyridin -2-yl)pyridin-2-amines contenant un groupe sulfoximine
NO20080302L (no)	2008-04-15	Humane anti-B7RP1 noytraliserende antistoffer
NO20074824L (no)	2007-11-21	Forlengelse av tid til sykdomsprogresjon eller overlevelse hos kreftpasienter
ATE527281T1 (de)	2011-10-15	Impfstoffe gegen aids umfassend cmv/r nucleinsäurekonstrukte
NO20083895L (no)	2008-10-24	Anti-IGF-1R human monoklonalantibody formulering
SG10201903538YA (en)	2019-05-30	Modified virus-like particles of cmv
NO20080951L (no)	2008-06-02	Farmasoytisk blanding for behandling av kardiovaskulaere lidelser
WO2006076003A3 (fr)	2007-06-28	Souches virales de vaccine
NO20082749L (no)	2008-06-13	Fremgangsmate for fremstilling av ferri-succinylkasein
NO20080993L (no)	2008-02-25	Fremgangsmate for a forbedre arvakenhet
CY1116135T1 (el)	2017-02-08	Εμβολιο ροταϊου που διεγειρει ετεροτυπικη εγκαρσια προστασια
UA112556C2 (uk)	2016-09-26	Інсектицидні похідні 2-метоксибензамідів
DE60011560D1 (de)	2004-07-22	Salmonella Impfstoff, der keinen Antikörper gegen Flagellin oder gegen Flagella induziert
WO2018066999A3 (fr)	2018-05-17	Particules pseudo-virale d'entérovirus chimériques
MX382687B (es)	2025-03-13	Composición resistente al agua.
WO2010028072A3 (fr)	2010-06-10	Anticorps aviaires spécifiques du virus de la grippe et procédés technologiquement simples de fabrication et d'utilisation de ceux-ci
TW200624479A (en)	2006-07-16	Film forming material and preparation of surface relief and optically anisotropic structures by irradiating a film of the said material
ATE471990T1 (de)	2010-07-15	Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln
WO2007136763A3 (fr)	2009-03-19	Composition immunologique
MX2007002659A (es)	2007-05-16	Composicion vacunal contra el virus de la hepatitis c.
WO2011022467A3 (fr)	2011-06-30	Formulations à libération contrôlée de composés anabaséine et utilisations de celles-ci
WO2007070678A3 (fr)	2008-06-19	Vaccin contre la rage
WO2009158409A3 (fr)	2010-03-18	Pimap39 modulant la réponse inflammatoire